文献速递眼底病与葡萄膜炎

Vogt-小柳-原田病诊断标准的开发与评估

Development and Evaluation of Diagnostic Criteria for Vogt-Koyanagi-Harada Disease.
PubMed 文献 · JAMA Ophthalmol · 2018-01-01

该病例对照研究利用中国南方634例VKH病患者和623例非VKH葡萄膜炎患者数据开发DCV诊断标准,并在北方537例确诊VKH病和525例非VKH葡萄膜炎患者中评估。DCV的敏感性和NPV高于RDC,特异性和PPV与RDC无差异,AUC为0.934。

要点

  • DCV敏感性94.6%高于RDC的71.9%,差异22.7%(95%CI 18.5-27.0)。
  • DCV的NPV 94.3%高于RDC的76.6%,差异17.7%(95%CI 13.9-21.5)。
  • DCV与RDC的特异性和PPV无显著差异,AUC分别为0.934和0.829。

核心结论

  • DCV在中国VKH病患者中显示出较高的敏感性、NPV和AUC,但基于回顾性分析开发,需在前瞻性研究和其他种族/民族人群中评估。

研究设计与样本

  • 开发队列:中国南方634例VKH病患者和623例非VKH葡萄膜炎患者。
  • 评估队列:中国北方537例确诊VKH病患者和525例非VKH葡萄膜炎患者。

主要发现

  • 开发队列1257例患者中665例(52.9%)为男性,平均发病年龄38.6(13.6)岁。
  • 通过潜在类别分析选择3类模型和21项临床表现,早期或晚期VKH组阳性率高或特异性高的变量构成基本参数。
  • DCV敏感性94.6% vs RDC 71.9%,差异22.7%(95%CI 18.5-27.0);DCV的NPV 94.3% vs RDC 76.6%,差异17.7%(95%CI 13.9-21.5)。
  • DCV特异性92.2% vs RDC 93.9%,差异1.7%(95%CI -1.4 to 4.8);DCV的PPV 89.3% vs RDC 92.3%,差异3.0%(95%CI -1.4 to 4.8)。
  • DCV的AUC为0.934(95%CI 0.917-0.951),RDC的AUC为0.829(95%CI 0.803-0.855)。

关键数值与推荐

  • DCV敏感性94.6%,NPV 94.3%,特异性92.2%,PPV 89.3%,AUC 0.934(95%CI 0.917-0.951)。
  • RDC敏感性71.9%,NPV 76.6%,特异性93.9%,PPV 92.3%,AUC 0.829(95%CI 0.803-0.855)。

临床怎么用

  • DCV可用于中国VKH病患者的诊断,其敏感性和NPV高于RDC,但需在前瞻性研究和其他种族/民族人群中进一步评估。

局限性

  • 原文述DCV基于回顾性分析开发,应在前瞻性研究和其他种族/民族人群中评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: To our knowledge, a set of well-defined diagnostic criteria is not yet developed for the diagnosis of Vogt-Koyanagi-Harada (VKH) disease. OBJECTIVE: To develop and evaluate a set of diagnostic criteria for VKH disease using data from Chinese patients. DESIGN, SETTING, AND PARTICIPANTS: This case-control study reviewed medical records of patients from a tertiary referral center between October 2011 and October 2016. Data from 634 patients with VKH disease and 623 patients with non-VKH uveitis from southern China were used to develop the Diagnostic Criteria for VKH Disease (DCV). Data from an additional group of 537 patients with a definite VKH disease diagnosis and 525 patients with non-VKH uveitis from northern China were used to evaluate the diagnostic criteria. MAIN OUTCOMES AND MEASURES: Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and receiver operating characteristic. RESULTS: Of the 1257 patients used to construct the DCV, 665 (52.9%) were male, and the mean (SD) age at disease onset was 38.6 (13.6) years. The 3-class model and 21 clinical findings were selected by latent class analysis. Variables with a high positive rate in the early-phase or late-phase VKH group or high specificity constituted essential parameters. Constellations of these essential parameters constructed the DCV. The sensitivity and NPV of the DCV were higher than those of the Revised Diagnostic Criteria for VKH Disease (RDC) (sensitivity: 94.6% vs 71.9%; difference, 22.7%; 95% CI, 18.5-27.0; NPV: 94.3% vs 76.6%; difference, 17.7%; 95% CI, 13.9-21.5). The specificity and PPV of the DCV were not different from that of the RDC (specificity: 92.2% vs 93.9%; difference, 1.7%; 95% CI, -1.4 to 4.8; PPV: 89.3% vs 92.3%; difference, 3.0%; 95% CI, -1.4 to 4.8). The area under the receiver operating characteristic curve of the DCV and the RDC were 0.934 (95% CI, 0.917-0.951) and 0.829 (95% CI, 0.803-0.855), respectively. CONCLUSIONS AND RELEVANCE: The DCV were developed and evaluated using data from Chinese patients with VKH disease and showed a high sensitivity, NPV, and area under the receiver operating characteristic curve in comparison with the RDC. However, they were developed using a retrospective analysis and should be evaluated in prospective studies in other racial/ethnic populations.

来源:JAMA Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Yang P, Zhong Y, Du L, et al. Development and Evaluation of Diagnostic Criteria for Vogt-Koyanagi-Harada Disease. JAMA Ophthalmol. 2018. PMID: 29978190. doi:10.1001/jamaophthalmol.2018.2664

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。